Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CPHPC is an inhibitor of the protein-protein interaction between serum amyloid P (SAP) and amyloid fibrils (IC50 = 0.9 µM).1 It also crosslinks with pentameric SAP in the plasma to form a decameric complex, which is eliminated via hepatic clearance. As plasma and amyloid deposits of SAP exist in a dynamic equilibrium, CPHPC induces the dissociation of SAP from tissue amyloid deposits, leading to its redistribution into the plasma, where it is eliminated. DPHC (1 mg/ml in the drinking water) reduces serum human SAP levels in a transgenic mouse model of amyloidosis.
WARNING This product is not for human or veterinary use.
1. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417(6886), 254-259 (2002).